FDA Clears Cepheid's GeneXpert Infinity-80 System | GenomeWeb

NEW YORK (GenomeWeb News) – Cepheid today announced the US Food and Drug Administration has cleared the GeneXpert Infinity-80 System in conjunction with its Xpert Flu test.

The GeneXpert Infinity-80 is a high-throughput, fully automated system designed to deliver around-the-clock results for various clinical testing applications, the Sunnyvale, Calif.-based company said. The system is designed to adapt to any workflow requirement including on-demand, batch, or STAT testing, and is available in configurations of 16, 24, 32, 40, 48, 56, 64, 72, and 80 modules.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.